Aesthetic medical device company Soliton Inc. (SOLY) is all set to report results of a pivotal clinical trial evaluating its Rapid Acoustic Pulse, or RAP, device for the treatment of cellulite on March 21, 2020.
from RTT - Biotech https://ift.tt/3aLXG8B
via IFTTT
No comments:
Post a Comment